Family Medicine · Lamar, MO
NPI
1942202080
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
805 Gulf St
Lamar, MO, 64759
Phone (417) 682-5508
Groups this clinician bills Medicare through
Medicare paid, 2024
$94K
6,358 services
Medicare patients, 2024
318
Average age 73
Drug cost, 2024
$1.4M
15,219 prescriptions
Company payments, 2025
$303
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clarence T Joustra was code J1010 (injection, methylprednisolone acetate, 1 mg), 3,669 times for 34 patients. In total Clarence T Joustra billed 6,358 services in 64 codes, and Medicare paid $94K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 3,669 | 34 | $0.09 | $333 |
| 99213 Office E&M - Established | Office | 800 | 218 | $45.56 | $36K |
| 99309 SNF E&M | Office | 446 | 58 | $54.93 | $24K |
| 36415 Venipuncture Blood Collection | Office | 290 | 143 | $8.62 | $2,500 |
| 83036 Blood Count | Office | 187 | 82 | $9.29 | $1,738 |
| 82947 Clinical Chemistry | Office | 184 | 82 | $3.76 | $691 |
| 98926 Spinal Manipulation | Office | 95 | 66 | $26.38 | $2,506 |
| 81002 Clinical Chemistry | Office | 84 | 49 | $3.41 | $286 |
| 98925 Spinal Manipulation | Office | 71 | 50 | $16.82 | $1,194 |
| 98927 Spinal Manipulation | Office | 71 | 33 | $34.46 | $2,447 |
| 98928 Spinal Manipulation | Office | 66 | 27 | $44.40 | $2,931 |
| 99214 Office E&M - Established | Office | 63 | 28 | $77.44 | $4,879 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 32 | 32 | $100.79 | $3,225 |
| 20610 Joint Injection | Office | 27 | 17 | $37.63 | $1,016 |
| 99306 SNF E&M | Office | 21 | 20 | $107.90 | $2,266 |
By year: 2022 $106K for 3,181 services; 2023 $114K for 3,109 services; 2024 $94K for 6,358 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 290 | 143 | $8.62 | $2,500 |
| 83036 Blood Count | 187 | 82 | $9.29 | $1,738 |
| 82947 Clinical Chemistry | 184 | 82 | $3.76 | $691 |
| 81002 Clinical Chemistry | 84 | 49 | $3.41 | $286 |
Medicare prescription drug claims, 2024
In 2024, the drug Clarence T Joustra prescribed most often to Medicare patients was Levothyroxine Sodium, with 561 prescriptions and refills. In total Clarence T Joustra wrote 15,219 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 561 | 926 | 83 | $3,618 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 440 | 440 | 68 | $14K |
| Lisinopril Generic | 423 | 762 | 81 | $1,954 |
| Gabapentin Generic | 409 | 590 | 61 | $4,913 |
| Amlodipine Besylate Generic | 357 | 670 | 68 | $1,759 |
| Carvedilol Generic | 319 | 640 | 66 | $1,922 |
| Omeprazole Generic | 313 | 481 | 63 | $3,636 |
| Eliquis Apixaban | 302 | 366 | 36 | $135K |
| Alprazolam Generic | 291 | 308 | 42 | $1,583 |
| Lorazepam Generic | 286 | 308 | 57 | $1,878 |
| Azithromycin Generic | 249 | 293 | 133 | $887 |
| Tamsulosin Hcl Generic | 247 | 401 | 44 | $3,169 |
| Metformin Hcl Generic | 239 | 448 | 48 | $1,095 |
| Tramadol Hcl Generic | 231 | 231 | 36 | $2,164 |
| Potassium Chloride Generic | 225 | 291 | 42 | $2,914 |
Brand drugs: 2,567 claims; generic drugs: 12,532 claims; opioid claims: 1,012.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clarence T Joustra $303 ($303 in general payments such as food, travel and fees) from 6 companies. The largest payer was Lundbeck LLC with $153.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.